Kenneth R. Deans Jr.
South Carolina
Kenneth R. Deans Jr. is a Contributing Writer for The American Quorum. With 30+ years of leadership across healthcare, technology, and education, he brings an experienced, independent perspective to issues shaping America.
Healthcare
FDA, CDC Expand Updated COVID-19 Vaccines to Children 6 Months and Older as Winter Campaign Broadens
Tech
FTC Sues to Block Microsoft’s $68.7 Billion Activision Deal, Citing Console, Subscription and Cloud-Gaming Risks
Healthcare
Lecanemab Slows Early Alzheimer’s Decline 27% in 1,795-Patient Phase 3 Trial, With ARIA-E Seen in 12.6%
Tech
OpenAI Releases ChatGPT Research Preview, Extending Human-Feedback Training Into a Conversational AI System
Healthcare
FDA Approves Hemgenix, First U.S. Gene Therapy for Hemophilia B, as One-Time Infusion Reduces Bleeding
Tech
FCC Blocks New Authorizations for Huawei, ZTE and Covered Chinese Security Equipment Under National-Security Rules
Healthcare
FDA Approves Tzield as First Drug to Delay Type 1 Diabetes, Using 14-Day Infusion Before Clinical Disease
Tech
Elizabeth Holmes Sentenced to 11 Years, 3 Months for Theranos Investor Fraud After Four-Count Conviction
Healthcare
Flu Hospitalization Rate Reaches 5.0 per 100,000 by Early November, Highest at This Point Since 2010–11
Tech
FTX Files Chapter 11 as Sam Bankman-Fried Resigns, Capping a Four-Day Liquidity Collapse That Sank Binance Rescue
Healthcare
Pfizer Maternal RSV Vaccine Cuts Severe Infant Illness 81.8% in First 90 Days in Phase 3 Interim Analysis
Tech
Twitter Cuts About Half Its Workforce One Week After Musk’s $44 Billion Takeover, Testing Moderation and Ad-Driven Business
Healthcare
Flu Hospitalizations Reach Highest Early-Season Level in a Decade as U.S. Activity Accelerates
Tech
Musk Closes $44 Billion Twitter Takeover at $54.20 a Share and Takes Sole Control of Board
Healthcare
CDC Allows Novavax as First COVID Booster for Adults Who Cannot or Will Not Take mRNA Shots
Tech
Netflix Adds 2.4 Million Subscribers, Reversing Losses as $6.99 Ad Tier Nears Launch
Healthcare
FDA and CDC Expand Omicron-Targeted COVID Boosters to Children as Young as 5
401 stories